help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokunaga, M.
Right arrow Articles by Sato, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokunaga, M.
Right arrow Articles by Sato, E.

American Journal of Pathology, Vol 143, 1263-1268, Copyright © 1993 by American Society for Investigative Pathology


REGULAR ARTICLES

Epstein-Barr virus in adult T-cell leukemia/lymphoma

M Tokunaga, S Imai, Y Uemura, T Tokudome, T Osato and E Sato
Department of Pathology, Kagoshima City Hospital, Japan.

Adult T-cell leukemia/lymphoma (ATLL) is a well-known human T-cell lymphotropic virus type-1-related disease. We studied Epstein-Barr virus (EBV) in the tumor cells of ATLL, to investigate the etiological significance of double infection with these viruses. We used polymerase chain reaction and EBV-encoded small RNA-1 in situ hybridization to investigate the presence of EBV and immunohistochemistry to detect EBV- related oncoproteins, such as EBV-determined nuclear antigen-2 and latent membrane protein. Polymerase chain reaction performed on DNA of frozen specimens from 96 cases of ATLL revealed that the tumor tissue from 21 cases contained EBV DNA. EBV-encoded small RNA-1 in situ hybridization performed on the paraffin sections of the polymerase chain reaction-positive cases indicated EBV in the nuclei of ATLL tumor cells in 16 cases, nine of which were in the pleomorphic nuclei. Latent membrane protein was also detected in the cytoplasm of ATLL tumor cells in 15 cases, and EBV nuclear antigen-2 was observed in the nuclei of ATLL tumor cells in 11 cases. We conclude that EBV was present within tumor cells in about 17% of cases with ATLL and expressed EBV oncoprotein in the tumor cells. It is hypothesized that EBV and human T- cell lymphotropic virus-1 may infect the same T cells in early life and may play a role in the oncogenesis of ATLL.


This article has been cited by other articles:


Home page
J. Virol.Home page
J. Xu, A. Ahmad, and J. Menezes
Preferential Localization of the Epstein-Barr Virus (EBV) Oncoprotein LMP-1 to Nuclei in Human T Cells: Implications for Its Role in the Development of EBV Genome-Positive T-Cell Lymphomas
J. Virol., March 19, 2002; 76(8): 4080 - 4086.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-i. Yasunaga, T. Sakai, K. Nosaka, K.-i. Etoh, S. Tamiya, S. Koga, S. Mita, M. Uchino, H. Mitsuya, and M. Matsuoka
Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state
Blood, May 15, 2001; 97(10): 3177 - 3183.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Society for Investigative Pathology.